What Happened?
Shares of fertility benefits company Progyny (NASDAQ: PGNY) jumped 2.4% in the afternoon session after Canaccord Genuity upgraded the company's stock to Buy from Hold and raised its price target.
The firm increased its price target on Progyny to $30 from $19. According to Canaccord, the upgrade was warranted because the company had beaten its quarterly revenue and adjusted EBITDA estimates for six consecutive quarters. The firm also noted it expected Progyny to return to double-digit revenue growth in the second half of 2026 as it moves past unfavorable comparisons from a previous agreement transition.
After the initial pop the shares cooled down to $24.67, up 2.6% from previous close.
Is now the time to buy Progyny? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Progyny’s shares are somewhat volatile and have had 12 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The previous big move we wrote about was 11 days ago when the stock gained 17.5% on the news that the company reported first-quarter 2026 financial results that surpassed analyst expectations and raised its full-year guidance.
The fertility benefits provider announced adjusted earnings of $0.50 per share, easily beating the consensus estimate of $0.44. Revenue for the quarter grew 1.4% year-over-year to $328.5 million, which also topped Wall Street's expectations. Looking ahead, the company provided an optimistic outlook, guiding for second-quarter revenue of $348.5 million at the midpoint, ahead of analyst forecasts.
Furthermore, Progyny slightly raised its revenue guidance for the full year and issued an EBITDA forecast that was also above expectations, signaling confidence in its business momentum.
Progyny is down 4.2% since the beginning of the year, and at $24.67 per share, it is trading 13.2% below its 52-week high of $28.42 from January 2026. Investors who bought $1,000 worth of Progyny’s shares 5 years ago would now be looking at only $445.07.
ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.
These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.
